529 related articles for article (PubMed ID: 33048840)
1. HBXIP promotes gastric cancer
Yang Z; Jiang X; Li D; Jiang X
Aging (Albany NY); 2020 Oct; 12(24):24967-24982. PubMed ID: 33048840
[TBL] [Abstract][Full Text] [Related]
2. HBXIP drives metabolic reprogramming in hepatocellular carcinoma cells via METTL3-mediated m6A modification of HIF-1α.
Yang N; Wang T; Li Q; Han F; Wang Z; Zhu R; Zhou J
J Cell Physiol; 2021 May; 236(5):3863-3880. PubMed ID: 33305825
[TBL] [Abstract][Full Text] [Related]
3. Dysregulated N6-methyladenosine methylation writer METTL3 contributes to the proliferation and migration of gastric cancer.
Liu T; Yang S; Sui J; Xu SY; Cheng YP; Shen B; Zhang Y; Zhang XM; Yin LH; Pu YP; Liang GY
J Cell Physiol; 2020 Jan; 235(1):548-562. PubMed ID: 31232471
[TBL] [Abstract][Full Text] [Related]
4. The m6A Methyltransferase METTL3-Mediated N6-Methyladenosine Modification of DEK mRNA to Promote Gastric Cancer Cell Growth and Metastasis.
Zhang HM; Qi FF; Wang J; Duan YY; Zhao LL; Wang YD; Zhang TC; Liao XH
Int J Mol Sci; 2022 Jun; 23(12):. PubMed ID: 35742899
[TBL] [Abstract][Full Text] [Related]
5. METTL3-mediated N6-methyladenosine modification is critical for epithelial-mesenchymal transition and metastasis of gastric cancer.
Yue B; Song C; Yang L; Cui R; Cheng X; Zhang Z; Zhao G
Mol Cancer; 2019 Oct; 18(1):142. PubMed ID: 31607270
[TBL] [Abstract][Full Text] [Related]
6. Methylation of microRNA-338-5p by EED promotes METTL3-mediated translation of oncogene CDCP1 in gastric cancer.
Zhang F; Yan Y; Cao X; Zhang J; Li Y; Guo C
Aging (Albany NY); 2021 Apr; 13(8):12224-12238. PubMed ID: 33882457
[TBL] [Abstract][Full Text] [Related]
7. HBXIP-elevated methyltransferase METTL3 promotes the progression of breast cancer via inhibiting tumor suppressor let-7g.
Cai X; Wang X; Cao C; Gao Y; Zhang S; Yang Z; Liu Y; Zhang X; Zhang W; Ye L
Cancer Lett; 2018 Feb; 415():11-19. PubMed ID: 29174803
[TBL] [Abstract][Full Text] [Related]
8. METTL3 regulates m6A in endometrioid epithelial ovarian cancer independently of METTl14 and WTAP.
Ma Z; Li Q; Liu P; Dong W; Zuo Y
Cell Biol Int; 2020 Dec; 44(12):2524-2531. PubMed ID: 32869897
[TBL] [Abstract][Full Text] [Related]
9. METTL3-mediated m
Wang Q; Chen C; Ding Q; Zhao Y; Wang Z; Chen J; Jiang Z; Zhang Y; Xu G; Zhang J; Zhou J; Sun B; Zou X; Wang S
Gut; 2020 Jul; 69(7):1193-1205. PubMed ID: 31582403
[TBL] [Abstract][Full Text] [Related]
10. The m6A methyltransferase METTL3 promotes osteosarcoma progression by regulating the m6A level of LEF1.
Miao W; Chen J; Jia L; Ma J; Song D
Biochem Biophys Res Commun; 2019 Aug; 516(3):719-725. PubMed ID: 31253399
[TBL] [Abstract][Full Text] [Related]
11. HDAC3-dependent transcriptional repression of FOXA2 regulates FTO/m6A/MYC signaling to contribute to the development of gastric cancer.
Yang Z; Jiang X; Zhang Z; Zhao Z; Xing W; Liu Y; Jiang X; Zhao H
Cancer Gene Ther; 2021 Feb; 28(1-2):141-155. PubMed ID: 32655129
[TBL] [Abstract][Full Text] [Related]
12. METTL3 Intensifies the Progress of Oral Squamous Cell Carcinoma via Modulating the m6A Amount of PRMT5 and PD-L1.
Ai Y; Liu S; Luo H; Wu S; Wei H; Tang Z; Li X; Lv X; Zou C
J Immunol Res; 2021; 2021():6149558. PubMed ID: 34476262
[TBL] [Abstract][Full Text] [Related]
13. METTL3 Promotes the Progression of Gastric Cancer via Targeting the MYC Pathway.
Yang DD; Chen ZH; Yu K; Lu JH; Wu QN; Wang Y; Ju HQ; Xu RH; Liu ZX; Zeng ZL
Front Oncol; 2020; 10():115. PubMed ID: 32175271
[TBL] [Abstract][Full Text] [Related]
14. [Methyltransferase-like 3 Promotes the Proliferation of Acute Myeloid Leukemia Cells by Regulating N6-methyladenosine Levels of MYC].
Wang XS; He JR; Yu S; Yu J
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2018 Jun; 40(3):308-314. PubMed ID: 29978784
[TBL] [Abstract][Full Text] [Related]
15. AGAP2-AS1 promotes the assembly of m6A methyltransferases and activation of the IL6/STAT3 pathway by binding with WTAP in the carcinogenesis of gastric cancer.
Nie K; Zheng Z; Li J; Chang Y; Deng Z; Huang W; Li X
FASEB J; 2023 Dec; 37(12):e23302. PubMed ID: 37983949
[TBL] [Abstract][Full Text] [Related]
16. RNA N6-methyladenosine methyltransferase-like 3 promotes liver cancer progression through YTHDF2-dependent posttranscriptional silencing of SOCS2.
Chen M; Wei L; Law CT; Tsang FH; Shen J; Cheng CL; Tsang LH; Ho DW; Chiu DK; Lee JM; Wong CC; Ng IO; Wong CM
Hepatology; 2018 Jun; 67(6):2254-2270. PubMed ID: 29171881
[TBL] [Abstract][Full Text] [Related]
17. Reduced m6A modification predicts malignant phenotypes and augmented Wnt/PI3K-Akt signaling in gastric cancer.
Zhang C; Zhang M; Ge S; Huang W; Lin X; Gao J; Gong J; Shen L
Cancer Med; 2019 Aug; 8(10):4766-4781. PubMed ID: 31243897
[TBL] [Abstract][Full Text] [Related]
18. RNA m
Luo G; Xu W; Zhao Y; Jin S; Wang S; Liu Q; Chen X; Wang J; Dong F; Hu DN; Reinach PS; Yan D
J Cell Physiol; 2020 Oct; 235(10):7107-7119. PubMed ID: 32017066
[TBL] [Abstract][Full Text] [Related]
19. N6-methyladenosine METTL3 promotes the breast cancer progression via targeting Bcl-2.
Wang H; Xu B; Shi J
Gene; 2020 Jan; 722():144076. PubMed ID: 31454538
[TBL] [Abstract][Full Text] [Related]
20. METTL3-mediated m
Huo FC; Zhu ZM; Zhu WT; Du QY; Liang J; Mou J
Oncogene; 2021 Apr; 40(16):2968-2981. PubMed ID: 33758320
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]